Stereotactic body radiotherapy for ventricular tachycardia (cardiac radiosurgery)
Tóm tắt
Single-session cardiac stereotactic body radiotherapy, called cardiac radiosurgery (CRS) or radioablation (RA), may offer a potential treatment option for patients with refractory ventricular tachycardia (VT) and electrical storm who are otherwise ineligible for catheter ablation. However, there is only limited clinical experience. We now present the first-in-patient treatment using (CRS/RA) for VT in Germany. A 78-year-old male patient with dilated cardiomyopathy and significantly reduced ejection fraction (15%) presented with monomorphic VT refractory to poly-anti-arrhythmic medication and causing multiple implantable cardioverter-defibrillator (ICD) interventions over the course of several weeks, necessitating prolonged treatment on an intensive care unit. Ultra-high-resolution electroanatomical voltage mapping (EVM) revealed a re-entry circuit in the cardiac septum inaccessible for catheter ablation. Based on the EVM, CRS/RA with a single session dose of 25 Gy (83% isodose) was delivered to the VT substrate (8.1 cc) using a c-arm-based high-precision linear accelerator on November 30, 2018. CRS/RA was performed without incident and dysfunction of the ICD was not observed. Following the procedure, a significant reduction in monomorphic VT from 5.0 to 1.6 episodes per week and of ICD shock interventions by 81.2% was observed. Besides periprocedural nausea with a single episode of vomiting, no treatment-associated side effects were noted. Unfortunately, the patient died 57 days after CRS/RA due to sepsis-associated cardiac circulatory failure after Clostridium difficile-associated colitis developed during rehabilitation. Histopathologic examination of the heart as part of a clinical autopsy revealed diffuse fibrosis on most sections of the heart without apparent differences between the target area and the posterior cardiac wall serving as a control. CRS/RA appears to be a possible treatment option for otherwise untreatable patients suffering from refractory VT and electrical storm. A relevant reduction in VT incidence and ICD interventions was observed, although long-term outcome and consequences of CRS/RA remain unclear. Clinical trials are strongly warranted and have been initiated.
Tài liệu tham khảo
Shivkumar K (2019) Catheter ablation of ventricular arrhythmias. N Engl J Med 380:1555–1564
Al-Khatib SM, Stevenson WG, Ackerman MJ et al (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm 15(10):e190–e252
Dukkipati SR, Koruth JS, Choudry S et al (2017) Catheter ablation of ventricular tachycardia in structural heart disease: indications, strategies, and outcomes-part II. J Am Coll Cardiol 70(23:2924–2941
Sapp JL, Wells GA, Parkash R et al (2016) Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 375(2):111–121
Tokuda M, Kojodjojo P, Tung S et al (2013) Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J Am Heart Assoc 2(3):e72
Santangeli P, Frankel DS, Tung R et al (2017) Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 69(17):2105–2115
Gianni C, Mohanty S, Trivedi C et al (2017) Alternative approaches for ablation of resistant ventricular tachycardia. Card Electrophysiol Clin 9(1):93–98
Sharma A, Wong D, Weidlich G et al (2010) Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm 7:802–810
Maguire PJ, Gardner E, Jack AB et al (2011) Cardiac Radiosurgery (CyberHeart) for treatment of arrhythmia: physiologic and histopathologic correlation in the porcine model. Cureus 3(8):e32
Loo BW Jr, Soltys SG, Wang L et al (2015) Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol 8(3):748–750
Cvek J, Neuwirth R, Knybel L et al (2014) Cardiac radiosurgery for malignant ventricular tachycardia. Cureus 6(7):e190
Cuculich PS, Schill MR, Kashani R et al (2017) Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med 377(24):2325–2336
Robinson CG, Samson PP, Moore KMS et al (2018) Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation 138:0–0
Knutson NC, Samson P, Hugo G et al (2019) Radiotherapy workflow and dosimetric analysis from a phase I/II trial of noninvasive cardiac radioablation for ventricular tachycardia. Int J Radiat Oncol Biol Phys 3016(19):30623–30626
Grimm J, LaCouture T, Croce R et al (2011) Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. J Appl Clin Med Phys 12(2):3368
Gauter-Fleckenstein B, Israel CW, Dorenkamp M et al (2015) DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol 191(5):393–404
Jumeau R, Ozsahin M, Schwitter J et al (2018) Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol 128(2):189–191
Neuwirth R, Cvek J, Knybel L et al (2019) Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace. 2019 Jul 1;21(7):1088–1095. https://doi.org/10.1093/europace/euz133
Scholz EP, Seidensaal K, Naumann P et al (2019) Risen from the dead: cardiac stereotactic ablative radiotherapy as last rescue in a patient with refractory ventricular fibrillation storm. HeartRhythm Case Rep. 2019 Mar 21;5(6):329–332. https://doi.org/10.1016/j.hrcr.2019.03.004
Stegner F, Hautmann MG, Suess C et al (2019) Radiotherapy of patients with cardiac Implantable electronic device according to the DEGRO/DGK guideline—is the risk for errors overestimated? Strahlenther Onkol. https://doi.org/10.1007/s00066-019-01502-0
Zei PC, Wong D, Gardner E et al (2018) Safety and efficacy of stereotactic radioablation targeting pulmonary vein tissues in an experimental model. Heart Rhythm 15(9):1420–1427
Blanck O, Bode F, Gebhard M et al (2014) Dose escalation study for cardiac radiosurgery in a porcine model. Int J Radiat Oncol Biol Phys 89(3):590–598
Bode F, Blanck O, Gebhard M et al (2015) Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation. Europace 17(12):1868–1874
Blanck O, Ipsen S, Chan MK et al (2016) Treatment planning considerations for robotic guided cardiac radiosurgery for atrial fibrillation. Cureus 8(7):e705
Monroy E, Azpiri J, De La Pena C et al (2016) Late gadolinium enhancement cardiac magnetic resonance imaging post-robotic radiosurgical pulmonary vein isolation (RRPVI): first case in the world. Cureus 8(8):e738
Di Biase L, Burkhardt JD, Lakkireddy D et al (2015) Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J Am Coll Cardiol 66(25):2872–2882
Bhaskaran A, Nayyar S, Porta-Sánchez A et al (2019) Exit sites on the epicardium rarely subtend critical diastolic path of ischemic VT on the endocardium: Implications for noninvasive ablation. J Cardiovasc Electrophysiol 30(4):520–527
Graham AJ, Orini M, Lambiase PD (2017) Limitations and challenges in mapping ventricular tachycardia: new technologies and future directions. Arrhythm Electrophysiol Rev 6(3):118–124
Moustakis C, Blanck O, Ebrahimi F et al (2017) Planning benchmark study for SBRT of early stage NSCLC: results of the DEGRO working group stereotactic radiotherapy. Strahlenther Onkol 193(10:780–790
Moustakis C, Chan MK, Kim J et al (2018) Treatment planning for spinal radiosurgery: a competitive multi-platform bench mark challenge. Strahlenther Onkol 194(9:843–854
Boda-Heggemann J, Jahnke A, Chan M et al (2019) In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations. Radiother Oncol 134:158–165
Weidlich GA, Hacker F, Bellezza D et al (2018) Ventricular tachycardia: a treatment comparison study of the CyberKnife with conventional linear accelerators. Cureus 10(10):e3445